After a long time of research in the field of oncology immunotherapy major breakthrough developments have been made. As a result, cancer vaccines seem to be the next generation of oncology treatments.
Vaccentis is exited to be part of this promising area with our All Individualized Precision Immunotherapy tumour vaccine technology - AIPI – to strengthen oncology treatments for patients!
